Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

National Monkeypox Surveillance, Central African Republic, 2001-2021

Camille Besombes et al. Emerg Infect Dis. 2022 Dec.

Abstract

We analyzed monkeypox disease surveillance in Central African Republic (CAR) during 2001-2021. Surveillance data show 95 suspected outbreaks, 40 of which were confirmed as monkeypox, comprising 99 confirmed and 61 suspected monkeypox cases. After 2018, CAR's annual rate of confirmed outbreaks increased, and 65% of outbreaks occurred in 2 forested regions bordering the Democratic Republic of the Congo. The median patient age for confirmed cases was 15.5 years. The overall case-fatality ratio was 7.5% (12/160) for confirmed and suspected cases, 9.6% (8/83) for children <16 years of age. Decreasing cross-protective immunity from smallpox vaccination and recent ecologic alterations likely contribute to increased monkeypox outbreaks in Central Africa. High fatality rates associated with monkeypox virus clade I also are a local and international concern. Ongoing investigations of zoonotic sources and environmental changes that increase human exposure could inform practices to prevent monkeypox expansion into local communities and beyond endemic areas.

Keywords: Central Africa; Central African Republic; emerging infectious diseases; monkeypox; monkeypox virus; national surveillance; outbreak investigation; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cases detected and investigated during national monkeypox surveillance, Central African Republic, 2001–2021.
Figure 2
Figure 2
Confirmed outbreaks detected during national monkeypox surveillance, Central African Republic, 2001–2021.
Figure 3
Figure 3
Confirmed outbreaks detected during national monkeypox surveillance, Central African Republic, 2001–2021. Source: Copernicus 2019 Global 100 m Landcover (https://doi.org/10.3390/rs12061044). Rep., Republic.
Figure 4
Figure 4
Frequency of signs and symptoms among 99 confirmed monkeypox cases detected during national surveillance, Central African Republic, 2001–2021.
Figure 5
Figure 5
Examples of rash severity detected during national monkeypox surveillance, Central African Republic, 2001–2021. A) Serious rash on a patient’s left hand. Serious rash was reported in 5.7% of cases. B) Moderate rash on a patient’s back. Moderate rash was reported in 57.1% of cases.
Figure 6
Figure 6
Example of fistulation of axillary adenopathy detected during national monkeypox surveillance, Central African Republic, 2001–2021.

References

    1. Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al.; SHARE-net Clinical Group. Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med. 2022;387:679–91. 10.1056/NEJMoa2207323 - DOI - PubMed
    1. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16:e0010141. 10.1371/journal.pntd.0010141 - DOI - PMC - PubMed
    1. Damon IK. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine. 2011;29(Suppl 4):D54–9. 10.1016/j.vaccine.2011.04.014 - DOI - PubMed
    1. Reynolds MG, Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol. 2012;20:80–7. 10.1016/j.tim.2011.12.001 - DOI - PubMed
    1. Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46:593–7. - PMC - PubMed

Publication types